Mail: info@sterilize.it  – Linkedin: sterilize.it


  • Member Area
  • Registration
  • About us
  • Processes
  • Applications
  • Bookstore
  • Useful Links
  • Contact us
  • About us
  • Processes
  • Applications
  • Bookstore
  • Useful Links
  • Contact us

Importance of risk assessment for aseptic transfer in pharmaceutical compounding

Abstract

Aseptic transfer is a critical contamination control issue, carried out over a series of stages. If any stage is performed in an uncontrolled  manner then microbial contamination of a product can occur. Contamination risks can arise from a number of sources, including incoming
materials, air and personnel. To address these risks appropriate controls include controlled environments, personnel gowning and  behaviour, and the use of disinfectants. This article considers the key risks and risk mitigation strategies using a case study of aseptic transfer
within a pharmacy unit for the purpose of preparation or compounding of a medicinal drug product.

 

Introduction

Aseptic transfer applies to various aspects of pharmaceuticals and healthcare, covering everything from the inoculation of agar plates in a microbiology laboratory to the transfer of items into a cleanroom as part of sterile products manufacturing or pharmaceutical compounding. Across this range of applications the overriding
requirement is asepsis, to either render the material free of microbial contamination (through bioburden reduction) or to prevent adventitious contamination, from operators or the environment, affecting the quality of the product or materials.

This article focuses on the best practices for aseptic transfer within a pharmaceutical facility or pharmacy specialising in drug compounding. Compounding is a process whereby the facility combines, mixes, or alters ingredients of a drug to create a medication suitable for the needs of patients. This can range from the larger scale production of intravenous bags of nutrient fluid for babies to the preparation of individual cytotoxic drugs.

With these activities microbialcontamination in the environment can result in product adulteration and, in turn, in a potential infection of the patient. In order to minimise the possibility of cross-contamination, a risk-centric approach is required. This is
a topical subject in light of several high profile product contamination events which have occurred worldwide (some with serious consequences for patients). […]

A courtesy of ‘Clean Air & Containment Review’ – www.cleanairandcontainment.com

  • author: Sandle Tim

The content you requested is only available for registered users. Please, register to download the file.
It's fast and free. Register here.
If you are a registered user enter your e-mail address and password to log in.

• Download
PDF File

0
0
0
0

related articles

  • Highlights on F0
  • Practical issues on PFS sterilization: an analysis of critical aspects
  • History of isolator and containment technology Part 1: Early containment leading to flexible film isolator
  • Implementing a fully integrated solution for the food canning industry
  • How does moist heat inactivate microorganisms?

0 Commenti

Leave Reply Annulla risposta

Il tuo indirizzo email non sarà pubblicato. I campi obbligatori sono contrassegnati *

Search
  • Enter your keyword

  • Processes

  • Applications

  • Author

Recent articles
  • A History of Isolator and Containment Technology, Part 5: Development and use of sterilising agents with associated devices
  • A history of isolator and containment technology Part 4: Transfer devices
  • A history of isolator and containment technology Part 3: Non-flexible film isolators including RABS
  • A history of isolator and containment technology Part 2: Flexible film isolators
  • Importance of risk assessment for aseptic transfer in pharmaceutical compounding

A history of isolator and containment technology, Part 6: Development of the validation of isolators

A history of isolator and containment technology Part 2: Flexible film isolators

Scroll
Contact

Mail: info@sterilize.it
Linkedin: sterilize.it

Member Area
Accesso
Password persa
Process
  • Aseptic processing
  • Cleaning
  • Chemical bio-decontamination
  • Moist-heat sterilization
  • Sterilization
Application
  • Blood bags
  • Environmental Monitoring
  • Food
  • General
  • Hyaluronic Acid
  • Other applications
  • Package Integrity
  • Pharma – Liquids
  • Pharmaceutical compounding
  • Pre-filled syringes (PFSs)
  • Robotics
  • Sealed containers
  • Validation
Subscribe to newsletter

Subscribe to our newsletter to stay informed about our news and info.

Join here

© Copyright 2020 Sterilize.it. All rights reserved. Privacy Policy e Cookie

Fedegari Autoclavi SpA | Albuzzano - SS 235 Km 8, CAP. 27010 (PV) | REA: PV- 130961 | P.IVA IT00303010185 | PEC: amministrazione@pec.fedegari.com | Capitale Sociale Versato 5.000.000,00 € i.v.